<XBRL>
<?xml version="1.0" encoding="UTF-8"?><!--EDGARizerX:  Instance document generated by EDGARizerX, version 3.5.3.0--><xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:asi="http://regeneron.com/20101026" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://xbrl.us/us-gaap/2009-01-31" xmlns:regn="http://regeneron.com/20100930" xmlns:dei="http://xbrl.us/dei/2009-01-31">
  <link:schemaRef xlink:type="simple" xlink:href="regn-20100930.xsd"/>
  <context id="c00000">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
    </entity>
    <period>
      <instant>2009-06-30</instant>
    </period>
  </context>
  <context id="c00001">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="c00002">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="c00003">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="c00004">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="c00005">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="c00006">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ComprehensiveIncomeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="c00007">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="c00008">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="c00009">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="c00010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="c00011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="c00012">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="c00013">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="c00014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="c00015">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="c00016">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="c00017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="c00018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="c00019">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="c00020">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="c00021">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="c00022">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="c00023">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="c00024">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="c00025">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="c00026">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="c00027">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ComprehensiveIncomeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="c00028">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="c00029">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="c00030">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="c00031">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="c00032">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="c00033">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="c00034">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ComprehensiveIncomeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="c00035">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="c00036">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="c00037">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="c00038">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="c00039">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="c00040">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ComprehensiveIncomeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="c00041">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="c00042">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
    </entity>
    <period>
      <startDate>2010-07-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="c00043">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
    </entity>
    <period>
      <startDate>2009-07-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="c00044">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
    </entity>
    <period>
      <instant>2010-10-15</instant>
    </period>
  </context>
  <unit id="u000">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="u001">
    <measure>xbrli:shares</measure>
  </unit>
  <!--Entity Voluntary Filers-->
  <dei:EntityVoluntaryFilers contextRef="c00035">No</dei:EntityVoluntaryFilers>
  <!--Document Fiscal Period Focus-->
  <dei:DocumentFiscalPeriodFocus contextRef="c00035">Q3</dei:DocumentFiscalPeriodFocus>
  <!--Change in net unrealized gain (loss) on marketable securities - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member] + Change in net unrealized gain (loss) on marketable securities - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member]-->
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax unitRef="u000" decimals="-3" contextRef="c00041">-1219000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <!--Change in net unrealized gain (loss) on marketable securities - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member] + Change in net unrealized gain (loss) on marketable securities - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member]-->
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax unitRef="u000" decimals="-3" contextRef="c00007">3651000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <!--Change in net unrealized gain (loss) on marketable securities - Total Stockholders' Equity + Change in net unrealized gain (loss) on marketable securities - Total Stockholders' Equity-->
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax unitRef="u000" decimals="-3" contextRef="c00035">-1219000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <!--Change in net unrealized gain (loss) on marketable securities - Total Stockholders' Equity + Change in net unrealized gain (loss) on marketable securities - Total Stockholders' Equity-->
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax unitRef="u000" decimals="-3" contextRef="c00001">3651000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <!--Change in net unrealized gain (loss) on marketable securities - Comprehensive Loss- Comprehensive Loss [Member] + Change in net unrealized gain (loss) on marketable securities - Comprehensive Loss- Comprehensive Loss [Member]-->
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax unitRef="u000" decimals="-3" contextRef="c00040">-1219000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <!--Change in net unrealized gain (loss) on marketable securities - Comprehensive Loss- Comprehensive Loss [Member] + Change in net unrealized gain (loss) on marketable securities - Comprehensive Loss- Comprehensive Loss [Member]-->
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax unitRef="u000" decimals="-3" contextRef="c00006">3651000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <!--Net increase in cash and cash equivalents-->
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="u000" decimals="-3" contextRef="c00035">118211000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <!--Net increase in cash and cash equivalents-->
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="u000" decimals="-3" contextRef="c00001">2525000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <!--Sales or maturities of marketable securities-->
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities unitRef="u000" decimals="-3" contextRef="c00035">230513000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
  <!--Sales or maturities of marketable securities-->
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities unitRef="u000" decimals="-3" contextRef="c00001">284934000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
  <!--Total expenses-->
  <us-gaap:CostsAndExpenses unitRef="u000" decimals="-3" contextRef="c00042">138073000</us-gaap:CostsAndExpenses>
  <!--Total expenses-->
  <us-gaap:CostsAndExpenses unitRef="u000" decimals="-3" contextRef="c00043">118746000</us-gaap:CostsAndExpenses>
  <!--Total expenses-->
  <us-gaap:CostsAndExpenses unitRef="u000" decimals="-3" contextRef="c00035">410094000</us-gaap:CostsAndExpenses>
  <!--Total expenses-->
  <us-gaap:CostsAndExpenses unitRef="u000" decimals="-3" contextRef="c00001">317163000</us-gaap:CostsAndExpenses>
  <!--Preferred stock, shares outstanding-->
  <us-gaap:PreferredStockSharesOutstanding unitRef="u001" decimals="0" contextRef="c00028">0</us-gaap:PreferredStockSharesOutstanding>
  <!--Preferred stock, shares outstanding-->
  <us-gaap:PreferredStockSharesOutstanding unitRef="u001" decimals="0" contextRef="c00015">0</us-gaap:PreferredStockSharesOutstanding>
  <!--Marketable securities-->
  <us-gaap:MarketableSecuritiesNoncurrent unitRef="u000" decimals="-3" contextRef="c00028">37956000</us-gaap:MarketableSecuritiesNoncurrent>
  <!--Marketable securities-->
  <us-gaap:MarketableSecuritiesNoncurrent unitRef="u000" decimals="-3" contextRef="c00015">47080000</us-gaap:MarketableSecuritiesNoncurrent>
  <!--Accounts receivable from the sanofi-aventis Group-->
  <us-gaap:DueFromRelatedPartiesCurrent unitRef="u000" decimals="-3" contextRef="c00028">79239000</us-gaap:DueFromRelatedPartiesCurrent>
  <!--Accounts receivable from the sanofi-aventis Group-->
  <us-gaap:DueFromRelatedPartiesCurrent unitRef="u000" decimals="-3" contextRef="c00015">62703000</us-gaap:DueFromRelatedPartiesCurrent>
  <!--Amendment Flag-->
  <dei:AmendmentFlag contextRef="c00035">false</dei:AmendmentFlag>
  <!--Issuance of Common Stock in connection with exercise of stock options, net of shares tendered - Common Stock Shares- Common Stock [Member] + Issuance of Common Stock in connection with exercise of stock options, net of shares tendered - Common Stock Shares- Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="u001" decimals="0" contextRef="c00036">993</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <!--Issuance of Common Stock in connection with exercise of stock options, net of shares tendered - Common Stock Shares- Common Stock [Member] + Issuance of Common Stock in connection with exercise of stock options, net of shares tendered - Common Stock Shares- Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="u001" decimals="0" contextRef="c00002">518</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <!--Cost of goods sold-->
  <us-gaap:CostOfGoodsSold unitRef="u000" decimals="-3" contextRef="c00042">372000</us-gaap:CostOfGoodsSold>
  <!--Cost of goods sold-->
  <us-gaap:CostOfGoodsSold unitRef="u000" decimals="-3" contextRef="c00043">472000</us-gaap:CostOfGoodsSold>
  <!--Cost of goods sold-->
  <us-gaap:CostOfGoodsSold unitRef="u000" decimals="-3" contextRef="c00035">1494000</us-gaap:CostOfGoodsSold>
  <!--Cost of goods sold-->
  <us-gaap:CostOfGoodsSold unitRef="u000" decimals="-3" contextRef="c00001">1299000</us-gaap:CostOfGoodsSold>
  <!--Technology licensing-->
  <us-gaap:LicensesRevenue unitRef="u000" decimals="-3" contextRef="c00042">10037000</us-gaap:LicensesRevenue>
  <!--Technology licensing-->
  <us-gaap:LicensesRevenue unitRef="u000" decimals="-3" contextRef="c00043">10000000</us-gaap:LicensesRevenue>
  <!--Technology licensing-->
  <us-gaap:LicensesRevenue unitRef="u000" decimals="-3" contextRef="c00035">30112000</us-gaap:LicensesRevenue>
  <!--Technology licensing-->
  <us-gaap:LicensesRevenue unitRef="u000" decimals="-3" contextRef="c00001">30000000</us-gaap:LicensesRevenue>
  <!--Deferred revenue - other-->
  <us-gaap:DeferredRevenueNoncurrent unitRef="u000" decimals="-3" contextRef="c00028">197139000</us-gaap:DeferredRevenueNoncurrent>
  <!--Deferred revenue - other-->
  <us-gaap:DeferredRevenueNoncurrent unitRef="u000" decimals="-3" contextRef="c00015">46951000</us-gaap:DeferredRevenueNoncurrent>
  <!--Property, plant, and equipment, at cost, net of accumulated  depreciation and amortization-->
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="u000" decimals="-3" contextRef="c00028">318498000</us-gaap:PropertyPlantAndEquipmentNet>
  <!--Property, plant, and equipment, at cost, net of accumulated  depreciation and amortization-->
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="u000" decimals="-3" contextRef="c00015">259676000</us-gaap:PropertyPlantAndEquipmentNet>
  <!--Interim Financial Statements-->
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c00035">&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 36pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;1.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Interim Financial Statements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The interim Condensed Financial State
ments of Regeneron Pharmaceuticals, Inc. (&amp;#8220;Regeneron&amp;#8221; or the &amp;#8220;Company&amp;#8221;) have been prepared in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X.&amp;#160;&amp;#160;Accordingly, they do not include all information and disclosures necessary for a presentation of the Company&amp;#8217;s financial position, results of operations, and cash flows in conformity with accounting principles generally accepted in the United States of America.&amp;#160;&amp;#160;In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring accruals, necessary for a fair presentation of the Company&amp;#8217;s financial position, results of operations, and cash flows for such periods.&amp;#160;&amp;#160;The results of operations for any interim periods are not necessarily indicative of the results for the full year.&amp;#160;&amp;#160;The December 31, 2009 Condensed Balance Sheet data were derived from audited fina
ncial statements, but do not include all disclosures required by accounting principles generally accepted in the United States of America.&amp;#160;&amp;#160;These financial statements should be read in conjunction with the financial statements and notes thereto contained in the Company&amp;#8217;s Annual Report on Form 10-K for the year ended December 31, 2009.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Effective in the first quarter of 2010, the estimated useful lives of certain capitalized laboratory and other equipment, which is a component of property, plant, and equipment, were extended.&amp;#160;&amp;#160;The effect of this change in estimate was to lower depreciation expense by $1.0 million and $3.0 million and to lower the Company&amp;#8217;s net loss per sh
are by $0.02 and $0.04 for the three and nine months ended September 30, 2010, respectively.&lt;/font&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <!--Entity Well-known Seasoned Issuer-->
  <dei:EntityWellKnownSeasonedIssuer contextRef="c00035">Yes</dei:EntityWellKnownSeasonedIssuer>
  <!--Prepaid expenses and other current assets-->
  <regn:PrepaidExpensesAndOtherCurrentAssets unitRef="u000" decimals="-3" contextRef="c00028">14379000</regn:PrepaidExpensesAndOtherCurrentAssets>
  <!--Prepaid expenses and other current assets-->
  <regn:PrepaidExpensesAndOtherCurrentAssets unitRef="u000" decimals="-3" contextRef="c00015">18610000</regn:PrepaidExpensesAndOtherCurrentAssets>
  <!--Marketable Securities-->
  <us-gaap:MarketableSecuritiesTextBlock contextRef="c00035">&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 36pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;5.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Marketable Securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Marketable securities at September 30, 2010 and December 31, 2009 consisted of debt securities,
 as detailed below, and an equity security, the aggregate fair value of which was $4.0 million and $5.5 million at September 30, 2010 and December 31, 2009, respectively, and the aggregate cost basis of which was $4.0 million at both September 30, 2010 and December 31, 2009.&amp;#160;&amp;#160;The following tables summarize the amortized cost basis of debt securities included in marketable securities, the aggregate fair value of those securities, and gross unrealized gains and losses on those securities at September 30, 2010 and December 31, 2009.&amp;#160;&amp;#160;The Company classifies its debt securities, other than mortgage-backed securities, based on their contractual maturity dates.&amp;#160;&amp;#160;Maturities of mortgage-backed securities have been estimated based primarily on repayment characteristics and experience of the senior tranches that the Company holds.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;#160;&lt;/div&gt;&lt;div&gt;&lt;table cellspacing="0" ce
llpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" width="31%" colspan="3"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; F
ONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="left" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;At September 30, 2010&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;Cost Basis&lt;/font&gt;&lt;/font&gt;&lt;/d
iv&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;&lt;font style="DISPLAY: inline"&gt;Value&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;font style="DISPLAY: inline"&gt;Gains&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0
pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;font style="DISPLAY: inline"&gt;(Losses)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;font style="DISPLAY: inline"&gt;Net&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Ma
turities within one year&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY
: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$106,140&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$106,238&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$101&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div style="DIS
PLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$(3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$98&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government guaranteed corporate bonds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SI
ZE: 10pt; FONT-FAMILY: times new roman"&gt;44,054&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;44,237&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;183&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAM
ILY: times new roman"&gt;183&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government guaranteed collateralized mortgage obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2,481&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2,611&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="
10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;130&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;130&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2p
x solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;689&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;681&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="BO
RDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(8)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(8)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEF
T: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;153,364&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;153,767&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;414&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top"
 align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(11)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;403&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Maturities between one and five years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="
11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government obligations
&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;9,046&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;9,072&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;26&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td va
lign="top" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;26&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government guaranteed corporate bonds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;21,502&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 
0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;21,829&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;327&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;327&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="jus
tify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Municipal bonds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2,206&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2,202&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div
 style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(8)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(4)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISP
LAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;842&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;675&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt
;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(167)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(167)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="ri
ght"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;33,596&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;33,778&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;357&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: bl
ock; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(175)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;182&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Maturities between five and seven years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 1
0pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORD
ER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;182&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;142&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt;&lt;/td&
gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(40)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(40)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new 
roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align
="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$187,142&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$187,687&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$771&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="11%"&gt;&lt;div style=
"DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$(226)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$545&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="left" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;At December 31, 2009&lt;/font&gt;&lt
;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FO
NT-FAMILY: times new roman"&gt;Maturities within one year&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="just
ify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;U.S. government obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$100,491&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$100,573&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$82&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="to
p" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$82&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government guaranteed corporate bonds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;17,176&lt;/font&gt;&lt;/div&
gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;17,340&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;164&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;164&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr
&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;Corporate bonds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;10,142&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;10,342&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font 
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;200&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;200&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government guaranteed collateralized mortgage obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 
0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;3,612&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;3,662&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;50&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0p
t" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;50&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;2,471&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&
lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;2,338&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$(133)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font
 style="DISPLAY: inline"&gt;(133)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;133,892&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;134,255&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 
2px solid" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;496&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(133)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;363&lt;/fo
nt&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Maturities between one and two years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%" colspan="2"&gt;&lt;fo
nt style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;U.S. government obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;9,413&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;9,367&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="10%"&
gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(46)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(46)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government guaranteed corporate bonds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;t
d valign="bottom" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;31,064&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;31,344&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;280&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right
" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;280&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;1,168&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width=
"11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;900&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(268)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="to
p" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(268)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;41,645&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" va
lign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;41,611&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;280&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(314)&lt;/font&gt;&lt;/font&gt;&lt
;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(34)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/t
d&gt;&lt;td valign="top" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="11%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="30%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$175,537&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MA
RGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$175,866&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$776&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$(447)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="11
%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$329&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;At December 31, 2009, marketable securities included an additional unrealized gain of $1.4 million related to the equity security in the Company&amp;#8217;s marketable securities portfolio.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline;
 FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The following table shows the fair value of the Company&amp;#8217;s marketable securities that have unrealized losses and that are deemed to be only temporarily impaired, aggregated by investment category and length of time that the individual securities have been in a continuous unrealized loss position, at September 30, 2010 and December 31, 2009.&amp;#160;&amp;#160;The debt securities listed at September 30, 2010, excluding mortgage-backed securities, mature at various dates through January 2012.&amp;#160;&amp;#160;The mortgage-backed securities listed at September 30, 2010 mature at various dates through November 2016.&lt;/font&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;#160;&lt;/div&gt;&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="top" width="24%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt
;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" width="20%" colspan="2"&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;Less than 12 Months&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" width="19%" colspan="2"&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;12 Months or Greater&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" width="20%" colspan="2
"&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;Total&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="left" width="24%"&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;At September 30, 2010&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" width="10%"&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;#160;&lt;/div&gt;&lt;div 
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;Fair Value&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized &lt;font style="DISPLAY: inline"&gt;Loss&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" width="9%"&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roma
n"&gt;&lt;font style="DISPLAY: inline"&gt;Fair Value&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized &lt;font style="DISPLAY: inline"&gt;Loss&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" width="11%"&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;Fair Value&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%"&gt;&lt;div style
="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized &lt;font style="DISPLAY: inline"&gt;Loss&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="24%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$12,624&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9.5pt" align="r
ight"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$(3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$12,624&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$(3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td val
ign="top" width="24%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Municipal bonds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,193&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(8)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="10%"&gt;&lt;font style="D
ISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,193&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(8)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="24%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="10%"&gt;&lt;font style="DISPLAY: inli
ne; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="9%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; $1,489&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$(215)&lt;/font&gt;&lt;/div&gt;&lt
;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,489&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(215)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="24%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Equity security&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGH
T: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;4,036&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(9)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="9%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 10.05pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; T
EXT-INDENT: 0pt; MARGIN-RIGHT: 8.35pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;4,036&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(9)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="24%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT
- -FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$17,853&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$(20)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 10.05pt" align="right"&gt;&lt;font style="DISPLAY: in
line; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$1,489&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 8.35pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$(215)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$19,342&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt;
 TEXT-INDENT: 0pt; MARGIN-RIGHT: 9.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$(235)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="24%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt
;/td&gt;&lt;td valign="bottom" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="24%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;At December 31, 2009&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#
160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="11%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="24%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="
DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$9,367&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$(46)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new
 roman"&gt;$9,367&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$(46)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="24%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="
right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 10.05pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$3,238&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 8.35pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$(401)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:
 black 2px solid" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;3,238&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(401)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="24%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: bl
ack 4px double" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$9,367&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$(46)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 10.05pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$3,2
38&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 8.35pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$(401)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="11%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$12,605&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE
: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;$(447)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Realized gains and losses are included as a component of investment income.&amp;#160;&amp;#160;For the three and nine months ended September 30, 2010 and 2009, realized gains and losses on sales of marketable securities were not significant.&amp;#160;&amp;#160;In computing realized gains and losses, the Company computes the cost of its investments on a specific identification basis.&amp;#160;&amp;#160;Such cost includes the direct costs to acquire the security, adjusted for the amortization of any discount or premium.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDEN
T: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company&amp;#8217;s assets that are measured at fair value on a recurring basis&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;,&lt;/font&gt; at September 30, 2010 and December 31, 2009, were as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&amp;#160;&lt;/div&gt;&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="top" width="29%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid; 
TEXT-ALIGN: center" valign="top" width="39%" colspan="3"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="font-family: temp; DISPLAY: inline"&gt;&amp;#160;&lt;font style="FONT-WEIGHT: bold"&gt;Fair Value Measurements at Reporting Date Using&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="29%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="12%"&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: 
times new roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;Fair Value&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="13%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Quoted Prices in Active Markets for Identical Assets&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;(Level 1)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="13%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: cent
er"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Significant Other Observable Inputs&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;(Level 2)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="12%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Significant Unobservable Inputs&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new rom
an"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;(Level 3)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="left" width="29%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;At September 30, 2010&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="13%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="13%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width=
"12%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="29%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Available-for-sale marketable securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="13%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="13%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top"
 width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="29%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="12%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$115,310&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="13%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="13%"&g
t;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 14.4pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$115,310&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="29%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government guaranteed corporate bonds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="12%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMI
LY: times new roman"&gt;66,066&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="13%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="13%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 14.4pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;66,066&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="29%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government guarantee
d collateralized mortgage obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="12%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2,611&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="13%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="13%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 14.4pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2,611&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;
/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="29%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Municipal bonds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="12%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2,202&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="13%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="13%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 14.4pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal
; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2,202&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="29%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="12%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,498&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="13%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FA
MILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="13%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 14.4pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,498&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="29%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Equity security&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="12%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-
RIGHT: 12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal"&gt;4,036&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="13%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 21.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal"&gt;$4,036&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="13%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 14.4pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width
="12%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="29%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="12%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal"&gt;$191,723&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="13%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 21.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font s
tyle="DISPLAY: inline; FONT-WEIGHT: normal"&gt;$4,036&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="13%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 14.4pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal"&gt;$187,687&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="29%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="13%
"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="13%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="left" width="29%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;At December 31, 2009&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" widt
h="13%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="13%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="29%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Available-for-sale marketable securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="13%"&gt;&lt;font style="DISPLAY:
 inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="13%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="29%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="12%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10
pt; FONT-FAMILY: times new roman"&gt;$109,940&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="13%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="13%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$109,940&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="29%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. governmen
t guaranteed corporate bonds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="12%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;48,684&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="13%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="13%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;48,684&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt
;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="29%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Corporate bonds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="12%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;10,342&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="13%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="13%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt;
 FONT-FAMILY: times new roman"&gt;10,342&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="29%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government guaranteed collateralized mortgage obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="12%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;3,662&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="13%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-S
IZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="13%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;3,662&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="29%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="12%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 
12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;3,238&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="13%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="13%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;3,238&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="29%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; F
ONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Equity security&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="12%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal"&gt;5,469&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="13%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 21.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal"&gt;$5,469&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="13%"&gt
;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 14.4pt" align="right"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="29%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="12%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 12.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal"&gt;$181,335&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="13%"&gt;&lt;div style=
"DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 21.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal"&gt;$5,469&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="13%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 14.4pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: normal"&gt;$175,866&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="12%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LE
FT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Marketable securities included in Level 2 were valued using a market approach utilizing prices and other relevant information, such as interest rates, yield curves, prepayment speeds, loss severities, credit risks and default rates, generated by market transactions involving identical or comparable assets.&amp;#160;&amp;#160;The Company considers market liquidity in determining the fair value for these securities.&amp;#160;&amp;#160;During the nine months ended September 30, 2010, deterioration in the credit quality of a marketable security from one issuer subjected the Company to the risk of not being able to recover the carrying value of the security.&amp;#160;&amp;#160;As a result, the Company recognized a $0.1 million impairment charge related to this Level 2 marketable security, which the Company considered to be other-than-temporarily impaired.&amp;#160;&a
mp;#160;During the three months ended September 30, 2010, and the three and nine months ended September 30, 2009, the Company did not record any charges for other-than-temporary impairment of its Level 2 marketable securities.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman"&gt;At December 31, 2008, the Company held one Level 3 marketable security whose fair value was $0.1 million.&amp;#160;&amp;#160;This Level 3 &lt;/font&gt;security was valued using information provided by the Company&amp;#8217;s investment advisors, including quoted bid prices which took into consideration the securities&amp;#8217; lack of liquidity.&amp;#160;&amp;#160;During the three and nine months ended September 30, 2009, the Company re
corded charges for other-than-temporary impairment of this Level 3 marketable security totaling $0.1 million. There were no purchases, sales, or maturities of Level 3 marketable securities and no unrealized gains or losses related to Level 3 marketable securities for the three and nine months ended September 30, 2010 and 2009.&amp;#160;&amp;#160;The Company held no Level 3 marketable securities at September 30, 2010 and December 31, 2009.&amp;#160;&amp;#160;There were no transfers of marketable securities between Levels 1, 2, or 3 classifications during the three and nine months ended September 30, 2010 and 2009.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On a quarterly basis, the Company reviews its portfolio of marketable securities, using both quantitative and qua
litative factors, to determine if declines in fair value below cost are other-than-temporary.&amp;#160;&amp;#160;With respect to debt securities, this review process also includes an evaluation of the Company&amp;#8217;s (a) intent to sell an individual debt security or (b) need to sell the debt security before its anticipated recovery or maturity.&amp;#160;&amp;#160;With respect to equity securities, this review process includes an evaluation of the Company&amp;#8217;s ability and intent to hold the securities until their full value can be recovered.&lt;/font&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
  <!--Document Type-->
  <dei:DocumentType contextRef="c00035">10-Q</dei:DocumentType>
  <!--Entity Public Float-->
  <dei:EntityPublicFloat unitRef="u000" decimals="0" contextRef="c00000">1355426000</dei:EntityPublicFloat>
  <!--Cash and cash equivalents at beginning of period + Cash and cash equivalents at end of period-->
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="u000" decimals="-3" contextRef="c00015">207075000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <!--Cash and cash equivalents at beginning of period + Cash and cash equivalents at end of period-->
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="u000" decimals="-3" contextRef="c00009">247796000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <!--Cash and cash equivalents at beginning of period + Cash and cash equivalents at end of period-->
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="u000" decimals="-3" contextRef="c00028">325286000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <!--Cash and cash equivalents at beginning of period + Cash and cash equivalents at end of period-->
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="u000" decimals="-3" contextRef="c00021">250321000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <!--Class A Stock, shares issued- Class A [Member]-->
  <us-gaap:CommonStockSharesIssued unitRef="u001" decimals="0" contextRef="c00029">2181831</us-gaap:CommonStockSharesIssued>
  <!--Class A Stock, shares issued- Class A [Member]-->
  <us-gaap:CommonStockSharesIssued unitRef="u001" decimals="0" contextRef="c00016">2244698</us-gaap:CommonStockSharesIssued>
  <!--Common Stock, shares issued-->
  <us-gaap:CommonStockSharesIssued unitRef="u001" decimals="0" contextRef="c00028">80042523</us-gaap:CommonStockSharesIssued>
  <!--Common Stock, shares issued-->
  <us-gaap:CommonStockSharesIssued unitRef="u001" decimals="0" contextRef="c00015">78860862</us-gaap:CommonStockSharesIssued>
  <!--Preferred stock, par value-->
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="u000" decimals="2" contextRef="c00028">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <!--Preferred stock, par value-->
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="u000" decimals="2" contextRef="c00015">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <!--Entity Central Index Key-->
  <dei:EntityCentralIndexKey contextRef="c00035">0000872589</dei:EntityCentralIndexKey>
  <!--Entity Current Reporting Status-->
  <dei:EntityCurrentReportingStatus contextRef="c00035">Yes</dei:EntityCurrentReportingStatus>
  <!--Net cash provided by financing activities-->
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="u000" decimals="-3" contextRef="c00035">60547000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <!--Net cash provided by financing activities-->
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="u000" decimals="-3" contextRef="c00001">9035000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <!--Net proceeds from the issuance of Common Stock-->
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="u000" decimals="-3" contextRef="c00035">13760000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <!--Net proceeds from the issuance of Common Stock-->
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="u000" decimals="-3" contextRef="c00001">4626000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <!--Purchases of marketable securities-->
  <us-gaap:PaymentsToAcquireMarketableSecurities unitRef="u000" decimals="-3" contextRef="c00035">241665000</us-gaap:PaymentsToAcquireMarketableSecurities>
  <!--Purchases of marketable securities-->
  <us-gaap:PaymentsToAcquireMarketableSecurities unitRef="u000" decimals="-3" contextRef="c00001">190666000</us-gaap:PaymentsToAcquireMarketableSecurities>
  <!--Decrease (Increase) in prepaid expenses and other assets-->
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="u000" decimals="-3" contextRef="c00035">-3446000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <!--Decrease (Increase) in prepaid expenses and other assets-->
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="u000" decimals="-3" contextRef="c00001">370000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <!--Preferred stock, shares authorized-->
  <us-gaap:PreferredStockSharesAuthorized unitRef="u001" decimals="0" contextRef="c00028">30000000</us-gaap:PreferredStockSharesAuthorized>
  <!--Preferred stock, shares authorized-->
  <us-gaap:PreferredStockSharesAuthorized unitRef="u001" decimals="0" contextRef="c00015">30000000</us-gaap:PreferredStockSharesAuthorized>
  <!--Current Fiscal Year End Date-->
  <dei:CurrentFiscalYearEndDate contextRef="c00035">--12-31</dei:CurrentFiscalYearEndDate>
  <!--Entity Registrant Name-->
  <dei:EntityRegistrantName contextRef="c00035">REGENERON PHARMACEUTICALS INC</dei:EntityRegistrantName>
  <!--Issuance of Common Stock in connection with exercise of stock options, net of shares tendered - Common Stock Amount- Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="u000" decimals="-3" contextRef="c00036">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <!--Issuance of Common Stock in connection with exercise of stock options, net of shares tendered - Additional Paid-in Capital- Additional Paid-in Capital [Member] + Issuance of Common Stock in connection with exercise of stock options, net of shares tendered - Additional Paid-in Capital- Additional Paid-in Capital [Member]-->
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="u000" decimals="-3" contextRef="c00037">13193000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <!--Issuance of Common Stock in connection with exercise of stock options, net of shares tendered - Additional Paid-in Capital- Additional Paid-in Capital [Member] + Issuance of Common Stock in connection with exercise of stock options, net of shares tendered - Additional Paid-in Capital- Additional Paid-in Capital [Member]-->
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="u000" decimals="-3" contextRef="c00003">4626000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <!--Issuance of Common Stock in connection with exercise of stock options, net of shares tendered - Total Stockholders' Equity + Issuance of Common Stock in connection with exercise of stock options, net of shares tendered - Total Stockholders' Equity-->
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="u000" decimals="-3" contextRef="c00035">13194000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <!--Issuance of Common Stock in connection with exercise of stock options, net of shares tendered - Total Stockholders' Equity + Issuance of Common Stock in connection with exercise of stock options, net of shares tendered - Total Stockholders' Equity-->
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="u000" decimals="-3" contextRef="c00001">4626000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <!--Loss from operations-->
  <us-gaap:OperatingIncomeLoss unitRef="u000" decimals="-3" contextRef="c00042">-32094000</us-gaap:OperatingIncomeLoss>
  <!--Loss from operations-->
  <us-gaap:OperatingIncomeLoss unitRef="u000" decimals="-3" contextRef="c00043">-1291000</us-gaap:OperatingIncomeLoss>
  <!--Loss from operations-->
  <us-gaap:OperatingIncomeLoss unitRef="u000" decimals="-3" contextRef="c00035">-84695000</us-gaap:OperatingIncomeLoss>
  <!--Loss from operations-->
  <us-gaap:OperatingIncomeLoss unitRef="u000" decimals="-3" contextRef="c00001">-34695000</us-gaap:OperatingIncomeLoss>
  <!--Total stockholders' equity + Balance, December 31, 2008 - Total Stockholders' Equity + Balance, September 30, 2009 - Total Stockholders' Equity-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00028">348064000</us-gaap:StockholdersEquity>
  <!--Total stockholders' equity + Balance, December 31, 2008 - Total Stockholders' Equity + Balance, September 30, 2009 - Total Stockholders' Equity-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00015">396762000</us-gaap:StockholdersEquity>
  <!--Total stockholders' equity + Balance, December 31, 2008 - Total Stockholders' Equity + Balance, September 30, 2009 - Total Stockholders' Equity-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00009">421514000</us-gaap:StockholdersEquity>
  <!--Total stockholders' equity + Balance, December 31, 2008 - Total Stockholders' Equity + Balance, September 30, 2009 - Total Stockholders' Equity-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00021">422443000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Class A Stock Amount- Class A [Member] + Balance, September 30, 2010 - Class A Stock Amount- Class A [Member] + Balance, December 31, 2008 - Class A Stock Amount- Class A [Member] + Balance, September 30, 2009 - Class A Stock Amount- Class A [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00016">2000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Class A Stock Amount- Class A [Member] + Balance, September 30, 2010 - Class A Stock Amount- Class A [Member] + Balance, December 31, 2008 - Class A Stock Amount- Class A [Member] + Balance, September 30, 2009 - Class A Stock Amount- Class A [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00029">2000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Class A Stock Amount- Class A [Member] + Balance, September 30, 2010 - Class A Stock Amount- Class A [Member] + Balance, December 31, 2008 - Class A Stock Amount- Class A [Member] + Balance, September 30, 2009 - Class A Stock Amount- Class A [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00010">2000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Class A Stock Amount- Class A [Member] + Balance, September 30, 2010 - Class A Stock Amount- Class A [Member] + Balance, December 31, 2008 - Class A Stock Amount- Class A [Member] + Balance, September 30, 2009 - Class A Stock Amount- Class A [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00022">2000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Common Stock Amount- Common Stock [Member] + Balance, September 30, 2010 - Common Stock Amount- Common Stock [Member] + Balance, December 31, 2008 - Common Stock Amount- Common Stock [Member] + Balance, September 30, 2009 - Common Stock Amount- Common Stock [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00017">79000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Common Stock Amount- Common Stock [Member] + Balance, September 30, 2010 - Common Stock Amount- Common Stock [Member] + Balance, December 31, 2008 - Common Stock Amount- Common Stock [Member] + Balance, September 30, 2009 - Common Stock Amount- Common Stock [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00030">80000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Common Stock Amount- Common Stock [Member] + Balance, September 30, 2010 - Common Stock Amount- Common Stock [Member] + Balance, December 31, 2008 - Common Stock Amount- Common Stock [Member] + Balance, September 30, 2009 - Common Stock Amount- Common Stock [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00011">78000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Common Stock Amount- Common Stock [Member] + Balance, September 30, 2010 - Common Stock Amount- Common Stock [Member] + Balance, December 31, 2008 - Common Stock Amount- Common Stock [Member] + Balance, September 30, 2009 - Common Stock Amount- Common Stock [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00023">78000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Additional Paid-in Capital- Additional Paid-in Capital [Member] + Balance, September 30, 2010 - Additional Paid-in Capital- Additional Paid-in Capital [Member] + Balance, December 31, 2008 - Additional Paid-in Capital- Additional Paid-in Capital [Member] + Balance, September 30, 2009 - Additional Paid-in Capital- Additional Paid-in Capital [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00018">1336732000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Additional Paid-in Capital- Additional Paid-in Capital [Member] + Balance, September 30, 2010 - Additional Paid-in Capital- Additional Paid-in Capital [Member] + Balance, December 31, 2008 - Additional Paid-in Capital- Additional Paid-in Capital [Member] + Balance, September 30, 2009 - Additional Paid-in Capital- Additional Paid-in Capital [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00031">1379123000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Additional Paid-in Capital- Additional Paid-in Capital [Member] + Balance, September 30, 2010 - Additional Paid-in Capital- Additional Paid-in Capital [Member] + Balance, December 31, 2008 - Additional Paid-in Capital- Additional Paid-in Capital [Member] + Balance, September 30, 2009 - Additional Paid-in Capital- Additional Paid-in Capital [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00012">1294813000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Additional Paid-in Capital- Additional Paid-in Capital [Member] + Balance, September 30, 2010 - Additional Paid-in Capital- Additional Paid-in Capital [Member] + Balance, December 31, 2008 - Additional Paid-in Capital- Additional Paid-in Capital [Member] + Balance, September 30, 2009 - Additional Paid-in Capital- Additional Paid-in Capital [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00024">1323432000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Accumulated Deficit- Accumulated Deficit [Member] + Balance, September 30, 2010 - Accumulated Deficit- Accumulated Deficit [Member] + Balance, December 31, 2008 - Accumulated Deficit- Accumulated Deficit [Member] + Balance, September 30, 2009 - Accumulated Deficit- Accumulated Deficit [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00019">-941095000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Accumulated Deficit- Accumulated Deficit [Member] + Balance, September 30, 2010 - Accumulated Deficit- Accumulated Deficit [Member] + Balance, December 31, 2008 - Accumulated Deficit- Accumulated Deficit [Member] + Balance, September 30, 2009 - Accumulated Deficit- Accumulated Deficit [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00032">-1030966000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Accumulated Deficit- Accumulated Deficit [Member] + Balance, September 30, 2010 - Accumulated Deficit- Accumulated Deficit [Member] + Balance, December 31, 2008 - Accumulated Deficit- Accumulated Deficit [Member] + Balance, September 30, 2009 - Accumulated Deficit- Accumulated Deficit [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00013">-873265000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Accumulated Deficit- Accumulated Deficit [Member] + Balance, September 30, 2010 - Accumulated Deficit- Accumulated Deficit [Member] + Balance, December 31, 2008 - Accumulated Deficit- Accumulated Deficit [Member] + Balance, September 30, 2009 - Accumulated Deficit- Accumulated Deficit [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00025">-904606000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member] + Balance, September 30, 2010 - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member] + Balance, December 31, 2008 - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member] + Balance, September 30, 2009 - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00020">1044000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member] + Balance, September 30, 2010 - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member] + Balance, December 31, 2008 - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member] + Balance, September 30, 2009 - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00033">-175000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member] + Balance, September 30, 2010 - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member] + Balance, December 31, 2008 - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member] + Balance, September 30, 2009 - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00014">-114000</us-gaap:StockholdersEquity>
  <!--Balance, December 31, 2009 - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member] + Balance, September 30, 2010 - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member] + Balance, December 31, 2008 - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member] + Balance, September 30, 2009 - Accumulated Other Comprehensive Income (Loss)- Accumulated Other Comprehensive Income (Loss) [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00026">3537000</us-gaap:StockholdersEquity>
  <!--Balance, September 30, 2010 - Comprehensive Loss- Comprehensive Loss [Member] + Balance, September 30, 2009 - Comprehensive Loss- Comprehensive Loss [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00034">-91090000</us-gaap:StockholdersEquity>
  <!--Balance, September 30, 2010 - Comprehensive Loss- Comprehensive Loss [Member] + Balance, September 30, 2009 - Comprehensive Loss- Comprehensive Loss [Member]-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00027">-27690000</us-gaap:StockholdersEquity>
  <!--Total liabilities-->
  <us-gaap:Liabilities unitRef="u000" decimals="-3" contextRef="c00028">594369000</us-gaap:Liabilities>
  <!--Total liabilities-->
  <us-gaap:Liabilities unitRef="u000" decimals="-3" contextRef="c00015">344440000</us-gaap:Liabilities>
  <!--Facility lease obligations-->
  <regn:FacilityLeaseObligationNoncurrent unitRef="u000" decimals="-3" contextRef="c00028">158382000</regn:FacilityLeaseObligationNoncurrent>
  <!--Facility lease obligations-->
  <regn:FacilityLeaseObligationNoncurrent unitRef="u000" decimals="-3" contextRef="c00015">109022000</regn:FacilityLeaseObligationNoncurrent>
  <!--Deferred revenue - other, current portion-->
  <us-gaap:DeferredRevenueCurrent unitRef="u000" decimals="-3" contextRef="c00028">38888000</us-gaap:DeferredRevenueCurrent>
  <!--Deferred revenue - other, current portion-->
  <us-gaap:DeferredRevenueCurrent unitRef="u000" decimals="-3" contextRef="c00015">27021000</us-gaap:DeferredRevenueCurrent>
  <!--Legal Matters-->
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c00035">&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 36pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;9.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Legal Matters&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;From time to time, the Company is a party to legal proceedings in the course of its bu
siness.&amp;#160;&amp;#160;The Company does not expect any such current legal proceedings to have a material adverse effect on the Company&amp;#8217;s business or financial condition.&lt;/font&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <!--Payments in connection with facility lease obligations-->
  <regn:PaymentsInConnectionWithFacilityLeaseObligation unitRef="u000" decimals="-3" contextRef="c00035">-757000</regn:PaymentsInConnectionWithFacilityLeaseObligation>
  <!--Payments in connection with facility lease obligations-->
  <regn:PaymentsInConnectionWithFacilityLeaseObligation unitRef="u000" decimals="-3" contextRef="c00001">-773000</regn:PaymentsInConnectionWithFacilityLeaseObligation>
  <!--Research and development-->
  <us-gaap:ResearchAndDevelopmentExpense unitRef="u000" decimals="-3" contextRef="c00042">122043000</us-gaap:ResearchAndDevelopmentExpense>
  <!--Research and development-->
  <us-gaap:ResearchAndDevelopmentExpense unitRef="u000" decimals="-3" contextRef="c00043">105434000</us-gaap:ResearchAndDevelopmentExpense>
  <!--Research and development-->
  <us-gaap:ResearchAndDevelopmentExpense unitRef="u000" decimals="-3" contextRef="c00035">364040000</us-gaap:ResearchAndDevelopmentExpense>
  <!--Research and development-->
  <us-gaap:ResearchAndDevelopmentExpense unitRef="u000" decimals="-3" contextRef="c00001">279972000</us-gaap:ResearchAndDevelopmentExpense>
  <!--Class A Stock, shares outstanding- Class A [Member]-->
  <us-gaap:CommonStockSharesOutstanding unitRef="u001" decimals="0" contextRef="c00029">2181831</us-gaap:CommonStockSharesOutstanding>
  <!--Class A Stock, shares outstanding- Class A [Member]-->
  <us-gaap:CommonStockSharesOutstanding unitRef="u001" decimals="0" contextRef="c00016">2244698</us-gaap:CommonStockSharesOutstanding>
  <!--Common Stock, shares outstanding-->
  <us-gaap:CommonStockSharesOutstanding unitRef="u001" decimals="0" contextRef="c00028">80042523</us-gaap:CommonStockSharesOutstanding>
  <!--Common Stock, shares outstanding-->
  <us-gaap:CommonStockSharesOutstanding unitRef="u001" decimals="0" contextRef="c00015">78860862</us-gaap:CommonStockSharesOutstanding>
  <!--Accounts payable and accrued expenses-->
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent unitRef="u000" decimals="-3" contextRef="c00028">74976000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <!--Accounts payable and accrued expenses-->
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent unitRef="u000" decimals="-3" contextRef="c00015">49031000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <!--Net cash provided by (used in) operating activities-->
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="u000" decimals="-3" contextRef="c00035">138043000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <!--Net cash provided by (used in) operating activities-->
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="u000" decimals="-3" contextRef="c00001">-25826000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <!--Weighted average shares outstanding, basic and diluted-->
  <regn:WeightedAverageSharesOutstandingBasicAndDiluted unitRef="u001" decimals="0" contextRef="c00042">81638</regn:WeightedAverageSharesOutstandingBasicAndDiluted>
  <!--Weighted average shares outstanding, basic and diluted-->
  <regn:WeightedAverageSharesOutstandingBasicAndDiluted unitRef="u001" decimals="0" contextRef="c00043">79866</regn:WeightedAverageSharesOutstandingBasicAndDiluted>
  <!--Weighted average shares outstanding, basic and diluted-->
  <regn:WeightedAverageSharesOutstandingBasicAndDiluted unitRef="u001" decimals="0" contextRef="c00035">81433</regn:WeightedAverageSharesOutstandingBasicAndDiluted>
  <!--Weighted average shares outstanding, basic and diluted-->
  <regn:WeightedAverageSharesOutstandingBasicAndDiluted unitRef="u001" decimals="0" contextRef="c00001">79663</regn:WeightedAverageSharesOutstandingBasicAndDiluted>
  <!--Other long term liabilities-->
  <us-gaap:OtherLiabilitiesNoncurrent unitRef="u000" decimals="-3" contextRef="c00028">5289000</us-gaap:OtherLiabilitiesNoncurrent>
  <!--Other long term liabilities-->
  <us-gaap:OtherLiabilitiesNoncurrent unitRef="u000" decimals="-3" contextRef="c00015">3959000</us-gaap:OtherLiabilitiesNoncurrent>
  <!--Future Impact of Recently Issued Accounting Standards-->
  <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock contextRef="c00035">&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 36pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;10.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Future Impact of Recently Issued Accounting Standards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In March 2010
, the FASB amended its authoritative guidance on the milestone method of revenue recognition.&amp;#160;&amp;#160;The milestone method of revenue recognition has now been codified as an acceptable revenue recognition model when a milestone is deemed to be substantive.&amp;#160;&amp;#160;This guidance may be applied retrospectively to all arrangements or prospectively for milestones achieved after the adoption of the guidance.&amp;#160;&amp;#160;The Company will adopt this amended guidance for the fiscal year beginning January 1, 2011.&amp;#160;&amp;#160;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman"&gt;Management does not anticipate that the adoption of &lt;/font&gt;this guidance &lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman"&gt;will have a material impact on the Company&amp;#8217;s financial statements.&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
  <!--Issuance of Common Stock in connection with Company 401(k) Savings Plan contribution - Additional Paid-in Capital- Additional Paid-in Capital [Member] + Issuance of Common Stock in connection with Company 401(k) Savings Plan contribution - Additional Paid-in Capital- Additional Paid-in Capital [Member]-->
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation unitRef="u000" decimals="-3" contextRef="c00037">2867000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <!--Issuance of Common Stock in connection with Company 401(k) Savings Plan contribution - Additional Paid-in Capital- Additional Paid-in Capital [Member] + Issuance of Common Stock in connection with Company 401(k) Savings Plan contribution - Additional Paid-in Capital- Additional Paid-in Capital [Member]-->
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation unitRef="u000" decimals="-3" contextRef="c00003">1391000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <!--Issuance of Common Stock in connection with Company 401(k) Savings Plan contribution - Total Stockholders' Equity + Issuance of Common Stock in connection with Company 401(k) Savings Plan contribution - Total Stockholders' Equity-->
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation unitRef="u000" decimals="-3" contextRef="c00035">2867000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <!--Issuance of Common Stock in connection with Company 401(k) Savings Plan contribution - Total Stockholders' Equity + Issuance of Common Stock in connection with Company 401(k) Savings Plan contribution - Total Stockholders' Equity-->
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation unitRef="u000" decimals="-3" contextRef="c00001">1391000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <!--Deferred revenue from sanofi-aventis-->
  <regn:DeferredRevenueFromRelatedPartyNoncurrent unitRef="u000" decimals="-3" contextRef="c00028">99726000</regn:DeferredRevenueFromRelatedPartyNoncurrent>
  <!--Deferred revenue from sanofi-aventis-->
  <regn:DeferredRevenueFromRelatedPartyNoncurrent unitRef="u000" decimals="-3" contextRef="c00015">90933000</regn:DeferredRevenueFromRelatedPartyNoncurrent>
  <!--Facility lease obligations, current portion-->
  <regn:FacilityLeaseObligationsCurrentPortion unitRef="u000" decimals="-3" contextRef="c00028">634000</regn:FacilityLeaseObligationsCurrentPortion>
  <!--Facility lease obligations, current portion-->
  <regn:FacilityLeaseObligationsCurrentPortion unitRef="u000" decimals="-3" contextRef="c00015">0</regn:FacilityLeaseObligationsCurrentPortion>
  <!--Total current assets-->
  <us-gaap:AssetsCurrent unitRef="u000" decimals="-3" contextRef="c00028">575719000</us-gaap:AssetsCurrent>
  <!--Total current assets-->
  <us-gaap:AssetsCurrent unitRef="u000" decimals="-3" contextRef="c00015">425508000</us-gaap:AssetsCurrent>
  <!--Accounts receivable - other-->
  <us-gaap:AccountsReceivableNetCurrent unitRef="u000" decimals="-3" contextRef="c00028">3048000</us-gaap:AccountsReceivableNetCurrent>
  <!--Accounts receivable - other-->
  <us-gaap:AccountsReceivableNetCurrent unitRef="u000" decimals="-3" contextRef="c00015">2865000</us-gaap:AccountsReceivableNetCurrent>
  <!--Subsequent Events-Public Offering of Common Stock-->
  <us-gaap:ScheduleOfSubsequentEventsTextBlock contextRef="c00035">&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 36pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;11.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Subsequent Event &amp;#8211; Public Offering of Common Stock&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In October 2010, the Company completed an underwr
itten public offering of 6,325,000 shares of Common Stock and received net proceeds of approximately $174.7 million.&lt;/font&gt;&lt;/div&gt;</us-gaap:ScheduleOfSubsequentEventsTextBlock>
  <!--Comprehensive Loss-->
  <us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="c00035">&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 36pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;7.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Comprehensive Income (Loss)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Comprehensive income (loss) of the Company includes net loss adjusted for the change i
n net unrealized gain (loss) on marketable securities, net of any tax effect.&amp;#160;&amp;#160;For the three and nine months ended September 30, 2010 and 2009, the components of comprehensive income (loss) are:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;#160;&lt;/div&gt;&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times ne
w roman"&gt;&lt;font style="DISPLAY: inline"&gt;Three months ended September 30,&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;
font style="DISPLAY: inline"&gt;2010&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;2009&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 1
0pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Net loss&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(33,875&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FA
MILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1,015&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman"&gt;Change in net unrealized gain (loss) on marketable securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;131&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" 
valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;2,523&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT
: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;&amp;#160;Total comprehensive (loss) income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(33,744&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY
: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;1,508&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt
;/div&gt;&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;Nine months ended September 30,&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: time
s new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;2010&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/
td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;2009&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FA
MILY: times new roman"&gt;Net loss&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(89,871&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLA
Y: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(31,341&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Change in net unrealized gain (loss) on marketable securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/t
d&gt;&lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(1,219&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FON
T-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;3,651&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;&amp;#160;Total comprehensive loss&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; 
FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(91,090&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="b
ottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(27,690&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
  <!--Statement of Cash Flows-->
  <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="c00035">&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 36pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;4.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Statement of Cash Flows&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Supplemental disclosure of noncash investing and financing activities:&lt;/font&gt
;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Included in accounts payable and accrued expenses at September 30, 2010 and December 31, 2009 were $12.0 million and $9.8 million, respectively, of accrued capital expenditures.&amp;#160;&amp;#160;Included in accounts payable and accrued expenses at September 30, 2009 and December 31, 2008 were $10.5 million and $7.0 million, respectively, of accrued capital expenditures.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Included in accounts payable and accrued expenses at December 31, 2009 and 2008 w
ere $2.6 million and $1.5 million, respectively, of accrued Company 401(k) Savings Plan contribution expense.&amp;#160;&amp;#160;In the first quarter of 2010 and 2009, the Company contributed 111,419 and 81,086 shares, respectively, of Common Stock to the 401(k) Savings Plan in satisfaction of these obligations.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Pursuant to the application of authoritative guidance issued by the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) to the Company&amp;#8217;s lease of office and laboratory facilities in Tarrytown, New York, the Company recognized a facility lease obligation of $4.0 million for the nine months ended September 30, 2009, in connection with capitalizing, on the Company&amp;#8217;s books, the landlord&
amp;#8217;s costs of constructing new facilities that the Company has leased.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Included in facility lease obligations and property, plant, and equipment at September 30, 2010 was $2.6 million of capitalized and deferred interest for the nine months ended September 30, 2010, as the related facilities being leased by the Company are currently under construction and lease payments on these facilities do not commence until January 2011.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Included 
in other assets at September 30, 2010 and December 31, 2009 was $0.1 million and $0.7 million, respectively, due to the Company in connection with employee exercises of stock options.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Included in marketable securities at September 30, 2010 and December 31, 2009 were $1.3 million and $0.6 million, respectively, of accrued interest income.&amp;#160;&amp;#160;Included in marketable securities at September 30, 2009 and December 31, 2008 were $1.0 million and $1.7 million, respectively, of accrued interest income.&lt;/font&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
  <!--Per Share Data-->
  <us-gaap:EarningsPerShareTextBlock contextRef="c00035">&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 36pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;3.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Per Share Data&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company&amp;#8217;s basic and diluted net loss per share amounts have been computed by dividing net lo
ss by the weighted average number of shares of Common Stock and Class A Stock outstanding.&amp;#160;&amp;#160;Net loss per share is presented on a combined basis, inclusive of Common Stock and Class A Stock outstanding, as each class of stock has equivalent economic rights.&amp;#160;&amp;#160;For the three and nine months ended September 30, 2010 and 2009, the Company reported net losses; therefore, no common stock equivalents were included in the computation of diluted net loss per share for these periods, since such inclusion would have been antidilutive.&amp;#160;&amp;#160;The calculations of basic and diluted net loss per share are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PA
DDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;Three Months Ended&amp;#160;September 30,&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-B
OTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;2010&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan=
"2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;2009&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Net loss (Numerator)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TE
XT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(33,875&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1,015&lt;/font&gt;&lt
;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY
: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;W
eighted-average shares, in thousands (Denominator)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;81,638&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" wid
th="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;79,866&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="
TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne
w roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Basic and diluted net loss per share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(0.41&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FA
MILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(0.01&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: in
line; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;Nine Months Ended&amp;#160;September 30,&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FO
NT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;2010&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&g
t;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;2009&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Net loss (Numerator)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: in
line; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(89,871&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt
;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(31,341&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" 
valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT
: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Weighted-average shares, in thousands (Denominator)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;81,433&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY
: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;79,663&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY:
 inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bo
ttom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Basic and diluted net loss per share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1.10&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: le
ft" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(0.39&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT
- -INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Shares issuable upon the exercise of stock options and vesting of restricted stock awards, which have been excluded from the September 30, 2010 and 2009 diluted per share amounts because their effect would have been antidilutive, include the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"&gt;&lt;div style="D
ISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;Three months ended September 30,&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; M
ARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;2010&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;2009&lt;/font&gt;&lt;/font&
gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Stock Options:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td
&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;Weighted average number, in thousands&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-
ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;21,265&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt
;19,860&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;Weighted average exercise price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FO
NT-FAMILY: times new roman"&gt;18.76&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;17.65&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&
lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bott
om" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Restricted Stock:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" w
idth="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;t
d style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;Weighted average number, in thousands&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new 
roman"&gt;511&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;500&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-IND
ENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;Nine months ended September 30,&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-S
IZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;2010&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;2009&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZ
E: 10pt; FONT-FAMILY: times new roman"&gt;Stock Options:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&
amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;Weighted average number, in thousands&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;21,317&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-S
IZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;20,059&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FON
T-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;Weighted average exercise price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;18.67&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left
" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;17.59&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt
;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMIL
Y: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Restricted Stock:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ti
mes new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#
160;&amp;#160;Weighted average number, in thousands&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;507&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width
="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;500&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <!--Issuance of Common Stock in connection with Company 401(k) Savings Plan contribution - Common Stock Shares- Common Stock [Member] + Issuance of Common Stock in connection with Company 401(k) Savings Plan contribution - Common Stock Shares- Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation unitRef="u001" decimals="0" contextRef="c00036">111</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <!--Issuance of Common Stock in connection with Company 401(k) Savings Plan contribution - Common Stock Shares- Common Stock [Member] + Issuance of Common Stock in connection with Company 401(k) Savings Plan contribution - Common Stock Shares- Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation unitRef="u001" decimals="0" contextRef="c00002">81</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <!--Increase in accounts receivable-->
  <us-gaap:IncreaseDecreaseInAccountsReceivable unitRef="u000" decimals="-3" contextRef="c00035">16719000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <!--Increase in accounts receivable-->
  <us-gaap:IncreaseDecreaseInAccountsReceivable unitRef="u000" decimals="-3" contextRef="c00001">32554000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <!--Net realized loss (gain) on marketable securities-->
  <us-gaap:GainLossOnInvestments unitRef="u000" decimals="-3" contextRef="c00035">-242000</us-gaap:GainLossOnInvestments>
  <!--Net realized loss (gain) on marketable securities-->
  <us-gaap:GainLossOnInvestments unitRef="u000" decimals="-3" contextRef="c00001">56000</us-gaap:GainLossOnInvestments>
  <!--Non-cash compensation expense-->
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="u000" decimals="-3" contextRef="c00035">26331000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Non-cash compensation expense-->
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="u000" decimals="-3" contextRef="c00001">22602000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Stock-based compensation expense - Additional Paid-in Capital- Additional Paid-in Capital [Member] + Stock-based compensation expense - Additional Paid-in Capital- Additional Paid-in Capital [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="u000" decimals="-3" contextRef="c00037">26331000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Stock-based compensation expense - Additional Paid-in Capital- Additional Paid-in Capital [Member] + Stock-based compensation expense - Additional Paid-in Capital- Additional Paid-in Capital [Member]-->
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="u000" decimals="-3" contextRef="c00003">22602000</us-gaap:AllocatedShareBasedCompensationExpense>
  <!--Total other income (expense)-->
  <us-gaap:NonoperatingIncomeExpense unitRef="u000" decimals="-3" contextRef="c00042">-1781000</us-gaap:NonoperatingIncomeExpense>
  <!--Total other income (expense)-->
  <us-gaap:NonoperatingIncomeExpense unitRef="u000" decimals="-3" contextRef="c00043">276000</us-gaap:NonoperatingIncomeExpense>
  <!--Total other income (expense)-->
  <us-gaap:NonoperatingIncomeExpense unitRef="u000" decimals="-3" contextRef="c00035">-5176000</us-gaap:NonoperatingIncomeExpense>
  <!--Total other income (expense)-->
  <us-gaap:NonoperatingIncomeExpense unitRef="u000" decimals="-3" contextRef="c00001">3354000</us-gaap:NonoperatingIncomeExpense>
  <!--Preferred stock, $.01 par value; 30,000,000 shares authorized; issued and outstanding - none-->
  <us-gaap:PreferredStockValue unitRef="u000" decimals="-3" contextRef="c00028">0</us-gaap:PreferredStockValue>
  <!--Preferred stock, $.01 par value; 30,000,000 shares authorized; issued and outstanding - none-->
  <us-gaap:PreferredStockValue unitRef="u000" decimals="-3" contextRef="c00015">0</us-gaap:PreferredStockValue>
  <!--Marketable securities-->
  <us-gaap:MarketableSecuritiesCurrent unitRef="u000" decimals="-3" contextRef="c00028">153767000</us-gaap:MarketableSecuritiesCurrent>
  <!--Marketable securities-->
  <us-gaap:MarketableSecuritiesCurrent unitRef="u000" decimals="-3" contextRef="c00015">134255000</us-gaap:MarketableSecuritiesCurrent>
  <!--Document Period End Date-->
  <dei:DocumentPeriodEndDate contextRef="c00035">2010-09-30</dei:DocumentPeriodEndDate>
  <!--Conversion of Class A Stock to Common Stock - Class A Stock Shares- Class A [Member] + Conversion of Class A Stock to Common Stock - Class A Stock Shares- Class A [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities unitRef="u001" decimals="0" contextRef="c00038">-63</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <!--Conversion of Class A Stock to Common Stock - Class A Stock Shares- Class A [Member] + Conversion of Class A Stock to Common Stock - Class A Stock Shares- Class A [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities unitRef="u001" decimals="0" contextRef="c00004">-2</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <!--Conversion of Class A Stock to Common Stock - Common Stock Shares- Common Stock [Member] + Conversion of Class A Stock to Common Stock - Common Stock Shares- Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities unitRef="u001" decimals="0" contextRef="c00036">63</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <!--Conversion of Class A Stock to Common Stock - Common Stock Shares- Common Stock [Member] + Conversion of Class A Stock to Common Stock - Common Stock Shares- Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities unitRef="u001" decimals="0" contextRef="c00002">2</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <!--Net cash (used in) provided by investing activities-->
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="u000" decimals="-3" contextRef="c00035">-80379000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <!--Net cash (used in) provided by investing activities-->
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="u000" decimals="-3" contextRef="c00001">19316000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <!--(Increase) decrease in restricted cash-->
  <us-gaap:IncreaseDecreaseInRestrictedCash unitRef="u000" decimals="-3" contextRef="c00035">1800000</us-gaap:IncreaseDecreaseInRestrictedCash>
  <!--(Increase) decrease in restricted cash-->
  <us-gaap:IncreaseDecreaseInRestrictedCash unitRef="u000" decimals="-3" contextRef="c00001">-50000</us-gaap:IncreaseDecreaseInRestrictedCash>
  <!--Net loss per share, basic and diluted-->
  <regn:NetLossPerShareBasicAndDiluted unitRef="u000" decimals="0" contextRef="c00042">-0.41</regn:NetLossPerShareBasicAndDiluted>
  <!--Net loss per share, basic and diluted-->
  <regn:NetLossPerShareBasicAndDiluted unitRef="u000" decimals="0" contextRef="c00043">-0.01</regn:NetLossPerShareBasicAndDiluted>
  <!--Net loss per share, basic and diluted-->
  <regn:NetLossPerShareBasicAndDiluted unitRef="u000" decimals="0" contextRef="c00035">-1.10</regn:NetLossPerShareBasicAndDiluted>
  <!--Net loss per share, basic and diluted-->
  <regn:NetLossPerShareBasicAndDiluted unitRef="u000" decimals="0" contextRef="c00001">-0.39</regn:NetLossPerShareBasicAndDiluted>
  <!--Selling, general, and administrative-->
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="u000" decimals="-3" contextRef="c00042">15658000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <!--Selling, general, and administrative-->
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="u000" decimals="-3" contextRef="c00043">12840000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <!--Selling, general, and administrative-->
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="u000" decimals="-3" contextRef="c00035">44560000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <!--Selling, general, and administrative-->
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="u000" decimals="-3" contextRef="c00001">35892000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <!--Total revenues-->
  <us-gaap:Revenues unitRef="u000" decimals="-3" contextRef="c00042">105979000</us-gaap:Revenues>
  <!--Total revenues-->
  <us-gaap:Revenues unitRef="u000" decimals="-3" contextRef="c00043">117455000</us-gaap:Revenues>
  <!--Total revenues-->
  <us-gaap:Revenues unitRef="u000" decimals="-3" contextRef="c00035">325399000</us-gaap:Revenues>
  <!--Total revenues-->
  <us-gaap:Revenues unitRef="u000" decimals="-3" contextRef="c00001">282468000</us-gaap:Revenues>
  <!--Contract research and other-->
  <us-gaap:ContractsRevenue unitRef="u000" decimals="-3" contextRef="c00042">1662000</us-gaap:ContractsRevenue>
  <!--Contract research and other-->
  <us-gaap:ContractsRevenue unitRef="u000" decimals="-3" contextRef="c00043">1793000</us-gaap:ContractsRevenue>
  <!--Contract research and other-->
  <us-gaap:ContractsRevenue unitRef="u000" decimals="-3" contextRef="c00035">5624000</us-gaap:ContractsRevenue>
  <!--Contract research and other-->
  <us-gaap:ContractsRevenue unitRef="u000" decimals="-3" contextRef="c00001">5229000</us-gaap:ContractsRevenue>
  <!--Additional paid-in capital-->
  <us-gaap:AdditionalPaidInCapital unitRef="u000" decimals="-3" contextRef="c00028">1379123000</us-gaap:AdditionalPaidInCapital>
  <!--Additional paid-in capital-->
  <us-gaap:AdditionalPaidInCapital unitRef="u000" decimals="-3" contextRef="c00015">1336732000</us-gaap:AdditionalPaidInCapital>
  <!--Common Stock A- Class A [Member]-->
  <us-gaap:CommonStockValue unitRef="u000" decimals="-3" contextRef="c00029">2000</us-gaap:CommonStockValue>
  <!--Common Stock A- Class A [Member]-->
  <us-gaap:CommonStockValue unitRef="u000" decimals="-3" contextRef="c00016">2000</us-gaap:CommonStockValue>
  <!--Common Stock-->
  <us-gaap:CommonStockValue unitRef="u000" decimals="-3" contextRef="c00028">80000</us-gaap:CommonStockValue>
  <!--Common Stock-->
  <us-gaap:CommonStockValue unitRef="u000" decimals="-3" contextRef="c00015">79000</us-gaap:CommonStockValue>
  <!--Issuance of restricted Common Stock under Long-Term Incentive Plan - Common Stock Shares- Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross unitRef="u001" decimals="0" contextRef="c00036">15</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
  <!--Balance, December 31, 2009 - Class A Stock Shares- Class A [Member] + Balance, September 30, 2010 - Class A Stock Shares- Class A [Member] + Balance, December 31, 2008 - Class A Stock Shares- Class A [Member] + Balance, September 30, 2009 - Class A Stock Shares- Class A [Member]-->
  <us-gaap:SharesIssued unitRef="u001" decimals="0" contextRef="c00016">2245</us-gaap:SharesIssued>
  <!--Balance, December 31, 2009 - Class A Stock Shares- Class A [Member] + Balance, September 30, 2010 - Class A Stock Shares- Class A [Member] + Balance, December 31, 2008 - Class A Stock Shares- Class A [Member] + Balance, September 30, 2009 - Class A Stock Shares- Class A [Member]-->
  <us-gaap:SharesIssued unitRef="u001" decimals="0" contextRef="c00029">2182</us-gaap:SharesIssued>
  <!--Balance, December 31, 2009 - Class A Stock Shares- Class A [Member] + Balance, September 30, 2010 - Class A Stock Shares- Class A [Member] + Balance, December 31, 2008 - Class A Stock Shares- Class A [Member] + Balance, September 30, 2009 - Class A Stock Shares- Class A [Member]-->
  <us-gaap:SharesIssued unitRef="u001" decimals="0" contextRef="c00010">2249</us-gaap:SharesIssued>
  <!--Balance, December 31, 2009 - Class A Stock Shares- Class A [Member] + Balance, September 30, 2010 - Class A Stock Shares- Class A [Member] + Balance, December 31, 2008 - Class A Stock Shares- Class A [Member] + Balance, September 30, 2009 - Class A Stock Shares- Class A [Member]-->
  <us-gaap:SharesIssued unitRef="u001" decimals="0" contextRef="c00022">2247</us-gaap:SharesIssued>
  <!--Balance, December 31, 2009 - Common Stock Shares- Common Stock [Member] + Balance, September 30, 2010 - Common Stock Shares- Common Stock [Member] + Balance, December 31, 2008 - Common Stock Shares- Common Stock [Member] + Balance, September 30, 2009 - Common Stock Shares- Common Stock [Member]-->
  <us-gaap:SharesIssued unitRef="u001" decimals="0" contextRef="c00017">78861</us-gaap:SharesIssued>
  <!--Balance, December 31, 2009 - Common Stock Shares- Common Stock [Member] + Balance, September 30, 2010 - Common Stock Shares- Common Stock [Member] + Balance, December 31, 2008 - Common Stock Shares- Common Stock [Member] + Balance, September 30, 2009 - Common Stock Shares- Common Stock [Member]-->
  <us-gaap:SharesIssued unitRef="u001" decimals="0" contextRef="c00030">80043</us-gaap:SharesIssued>
  <!--Balance, December 31, 2009 - Common Stock Shares- Common Stock [Member] + Balance, September 30, 2010 - Common Stock Shares- Common Stock [Member] + Balance, December 31, 2008 - Common Stock Shares- Common Stock [Member] + Balance, September 30, 2009 - Common Stock Shares- Common Stock [Member]-->
  <us-gaap:SharesIssued unitRef="u001" decimals="0" contextRef="c00011">77642</us-gaap:SharesIssued>
  <!--Balance, December 31, 2009 - Common Stock Shares- Common Stock [Member] + Balance, September 30, 2010 - Common Stock Shares- Common Stock [Member] + Balance, December 31, 2008 - Common Stock Shares- Common Stock [Member] + Balance, September 30, 2009 - Common Stock Shares- Common Stock [Member]-->
  <us-gaap:SharesIssued unitRef="u001" decimals="0" contextRef="c00023">78243</us-gaap:SharesIssued>
  <!--Proceeds in connection with facility lease obligations-->
  <regn:ProceedsFromFacilityLeaseObligation unitRef="u000" decimals="-3" contextRef="c00035">47544000</regn:ProceedsFromFacilityLeaseObligation>
  <!--Proceeds in connection with facility lease obligations-->
  <regn:ProceedsFromFacilityLeaseObligation unitRef="u000" decimals="-3" contextRef="c00001">5182000</regn:ProceedsFromFacilityLeaseObligation>
  <!--Investment income-->
  <us-gaap:InvestmentIncomeNonoperating unitRef="u000" decimals="-3" contextRef="c00042">453000</us-gaap:InvestmentIncomeNonoperating>
  <!--Investment income-->
  <us-gaap:InvestmentIncomeNonoperating unitRef="u000" decimals="-3" contextRef="c00043">857000</us-gaap:InvestmentIncomeNonoperating>
  <!--Investment income-->
  <us-gaap:InvestmentIncomeNonoperating unitRef="u000" decimals="-3" contextRef="c00035">1484000</us-gaap:InvestmentIncomeNonoperating>
  <!--Investment income-->
  <us-gaap:InvestmentIncomeNonoperating unitRef="u000" decimals="-3" contextRef="c00001">3935000</us-gaap:InvestmentIncomeNonoperating>
  <!--Net product sales-->
  <us-gaap:SalesRevenueGoodsNet unitRef="u000" decimals="-3" contextRef="c00042">4936000</us-gaap:SalesRevenueGoodsNet>
  <!--Net product sales-->
  <us-gaap:SalesRevenueGoodsNet unitRef="u000" decimals="-3" contextRef="c00043">4973000</us-gaap:SalesRevenueGoodsNet>
  <!--Net product sales-->
  <us-gaap:SalesRevenueGoodsNet unitRef="u000" decimals="-3" contextRef="c00035">19985000</us-gaap:SalesRevenueGoodsNet>
  <!--Net product sales-->
  <us-gaap:SalesRevenueGoodsNet unitRef="u000" decimals="-3" contextRef="c00001">13364000</us-gaap:SalesRevenueGoodsNet>
  <!--Other assets-->
  <us-gaap:OtherAssetsNoncurrent unitRef="u000" decimals="-3" contextRef="c00028">6860000</us-gaap:OtherAssetsNoncurrent>
  <!--Other assets-->
  <us-gaap:OtherAssetsNoncurrent unitRef="u000" decimals="-3" contextRef="c00015">7338000</us-gaap:OtherAssetsNoncurrent>
  <!--Document Fiscal Year Focus-->
  <dei:DocumentFiscalYearFocus contextRef="c00035">2010</dei:DocumentFiscalYearFocus>
  <!--Increase in accounts payable, accrued expenses, and other liabilities-->
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities unitRef="u000" decimals="-3" contextRef="c00035">28353000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <!--Increase in accounts payable, accrued expenses, and other liabilities-->
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities unitRef="u000" decimals="-3" contextRef="c00001">17960000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <!--Interest expense-->
  <us-gaap:InterestExpense unitRef="u000" decimals="-3" contextRef="c00042">2234000</us-gaap:InterestExpense>
  <!--Interest expense-->
  <us-gaap:InterestExpense unitRef="u000" decimals="-3" contextRef="c00043">581000</us-gaap:InterestExpense>
  <!--Interest expense-->
  <us-gaap:InterestExpense unitRef="u000" decimals="-3" contextRef="c00035">6660000</us-gaap:InterestExpense>
  <!--Interest expense-->
  <us-gaap:InterestExpense unitRef="u000" decimals="-3" contextRef="c00001">581000</us-gaap:InterestExpense>
  <!--Class A Stock, shares authorized- Class A [Member]-->
  <us-gaap:CommonStockSharesAuthorized unitRef="u001" decimals="0" contextRef="c00029">40000000</us-gaap:CommonStockSharesAuthorized>
  <!--Class A Stock, shares authorized- Class A [Member]-->
  <us-gaap:CommonStockSharesAuthorized unitRef="u001" decimals="0" contextRef="c00016">40000000</us-gaap:CommonStockSharesAuthorized>
  <!--Common Stock, shares authorized-->
  <us-gaap:CommonStockSharesAuthorized unitRef="u001" decimals="0" contextRef="c00028">160000000</us-gaap:CommonStockSharesAuthorized>
  <!--Common Stock, shares authorized-->
  <us-gaap:CommonStockSharesAuthorized unitRef="u001" decimals="0" contextRef="c00015">160000000</us-gaap:CommonStockSharesAuthorized>
  <!--Class A Stock, par value- Class A [Member]-->
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="u000" decimals="3" contextRef="c00029">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <!--Class A Stock, par value- Class A [Member]-->
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="u000" decimals="3" contextRef="c00016">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <!--Common Stock, par value-->
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="u000" decimals="3" contextRef="c00028">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <!--Common Stock, par value-->
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="u000" decimals="3" contextRef="c00015">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <!--Accumulated deficit-->
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="u000" decimals="-3" contextRef="c00028">-1030966000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <!--Accumulated deficit-->
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="u000" decimals="-3" contextRef="c00015">-941095000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <!--Net loss-->
  <us-gaap:NetIncomeLoss unitRef="u000" decimals="-3" contextRef="c00042">-33875000</us-gaap:NetIncomeLoss>
  <!--Net loss-->
  <us-gaap:NetIncomeLoss unitRef="u000" decimals="-3" contextRef="c00043">-1015000</us-gaap:NetIncomeLoss>
  <!--Net loss-->
  <us-gaap:NetIncomeLoss unitRef="u000" decimals="-3" contextRef="c00035">-89871000</us-gaap:NetIncomeLoss>
  <!--Net loss-->
  <us-gaap:NetIncomeLoss unitRef="u000" decimals="-3" contextRef="c00001">-31341000</us-gaap:NetIncomeLoss>
  <!--Net loss - Accumulated Deficit- Accumulated Deficit [Member] + Net loss - Accumulated Deficit- Accumulated Deficit [Member]-->
  <us-gaap:NetIncomeLoss unitRef="u000" decimals="-3" contextRef="c00039">-89871000</us-gaap:NetIncomeLoss>
  <!--Net loss - Accumulated Deficit- Accumulated Deficit [Member] + Net loss - Accumulated Deficit- Accumulated Deficit [Member]-->
  <us-gaap:NetIncomeLoss unitRef="u000" decimals="-3" contextRef="c00005">-31341000</us-gaap:NetIncomeLoss>
  <!--Net loss - Comprehensive Loss- Comprehensive Loss [Member] + Net loss - Comprehensive Loss- Comprehensive Loss [Member]-->
  <us-gaap:NetIncomeLoss unitRef="u000" decimals="-3" contextRef="c00040">-89871000</us-gaap:NetIncomeLoss>
  <!--Net loss - Comprehensive Loss- Comprehensive Loss [Member] + Net loss - Comprehensive Loss- Comprehensive Loss [Member]-->
  <us-gaap:NetIncomeLoss unitRef="u000" decimals="-3" contextRef="c00006">-31341000</us-gaap:NetIncomeLoss>
  <!--Preferred stock, shares issued-->
  <us-gaap:PreferredStockSharesIssued unitRef="u001" decimals="0" contextRef="c00028">0</us-gaap:PreferredStockSharesIssued>
  <!--Preferred stock, shares issued-->
  <us-gaap:PreferredStockSharesIssued unitRef="u001" decimals="0" contextRef="c00015">0</us-gaap:PreferredStockSharesIssued>
  <!--Deferred revenue from sanofi-aventis, current portion-->
  <regn:DeferredRevenueFromRelatedPartyCurrent unitRef="u000" decimals="-3" contextRef="c00028">19335000</regn:DeferredRevenueFromRelatedPartyCurrent>
  <!--Deferred revenue from sanofi-aventis, current portion-->
  <regn:DeferredRevenueFromRelatedPartyCurrent unitRef="u000" decimals="-3" contextRef="c00015">17523000</regn:DeferredRevenueFromRelatedPartyCurrent>
  <!--Extension of Technology Licensing Agreement with Astellas-->
  <regn:ExtensionOfTechnologyLicensingAgreementWithAstellas contextRef="c00035">&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 36pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;8.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Extension of Technology Licensing Agreement with Astellas&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In March 2007, the Company entered into 
a six-year non-exclusive license agreement with Astellas Pharma Inc. that allows Astellas to utilize the Company&amp;#8217;s &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;VelocImmune&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;technology in its internal research programs to discover human monoclonal antibodies.&amp;#160;&amp;#160;Under the terms of the agreement, Astellas made a $20.0 million annual, non-refundable payment to the Company in each of 2010, 2009, 2008, and 2007.&amp;#160;&amp;#160;In July 2010, the license agreement with Astellas was amended and extended through June 2023.&amp;#160;&amp;#160;Under the terms of the amended agreement, Astellas made a $165.0 million up-front payment to the Company in August 2010, which &lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman"&gt;was deferred upon receipt and will be recognized as revenue
 ratably over the seven-year period beginning in mid-2011.&lt;/font&gt;&amp;#160;&amp;#160;In addition, Astellas will make a $130.0 million second payment to the Company in June 2018 unless the license agreement has been terminated prior to that date.&amp;#160;&amp;#160;Astellas has the right to terminate the agreement at any time by providing 90 days&amp;#8217; advance written notice.&amp;#160;&amp;#160;&lt;font style="DISPLAY: inline; FONT-FAMILY: Times New Roman"&gt;Under certain limited circumstances, such as a material breach of the agreement by the Company, Astellas may terminate the agreement and receive a refund of a portion of its up-front payment or, if such termination occurs after June 2018, a portion of its second payment, to the Company under the July 2010 amendment to the agreement.&lt;/font&gt;&amp;#160;&amp;#160;The Company is entitled to receive a mid-single-digit royalty on any future sales of antibody products discovered by Astellas using the Company&amp;#8217;s &lt;font style="DISPLAY: i
nline; FONT-STYLE: italic"&gt;VelocImmune&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; technology.&amp;#160;&amp;#160;In connection with the Astellas license agreement, the Company recognized $15.0 million of technology revenue for both the nine months ended September 30, 2010 and 2009.&amp;#160;&amp;#160;In addition, deferred revenue at September 30, 2010 and December 31, 2009 was $178.7 million and $8.7 million, respectively.&lt;/font&gt;&lt;/div&gt;</regn:ExtensionOfTechnologyLicensingAgreementWithAstellas>
  <!--Sanofi-aventis collaboration revenue-->
  <regn:SanofiAventisCollaborationRevenue unitRef="u000" decimals="-3" contextRef="c00042">75583000</regn:SanofiAventisCollaborationRevenue>
  <!--Sanofi-aventis collaboration revenue-->
  <regn:SanofiAventisCollaborationRevenue unitRef="u000" decimals="-3" contextRef="c00043">68536000</regn:SanofiAventisCollaborationRevenue>
  <!--Sanofi-aventis collaboration revenue-->
  <regn:SanofiAventisCollaborationRevenue unitRef="u000" decimals="-3" contextRef="c00035">229195000</regn:SanofiAventisCollaborationRevenue>
  <!--Sanofi-aventis collaboration revenue-->
  <regn:SanofiAventisCollaborationRevenue unitRef="u000" decimals="-3" contextRef="c00001">178928000</regn:SanofiAventisCollaborationRevenue>
  <!--Total assets-->
  <us-gaap:Assets unitRef="u000" decimals="-3" contextRef="c00028">942433000</us-gaap:Assets>
  <!--Total assets-->
  <us-gaap:Assets unitRef="u000" decimals="-3" contextRef="c00015">741202000</us-gaap:Assets>
  <!--Commitments and contingencies-->
  <us-gaap:CommitmentsAndContingencies2009 contextRef="c00035"/>
  <!--Commitments and contingencies-->
  <us-gaap:CommitmentsAndContingencies2009 contextRef="c00008"/>
  <!--Accounts Payable and Accrued Expenses-->
  <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c00035">&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 36pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;6.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Accounts Payable and Accrued Expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Accounts payable and accrued expenses as of September
 30, 2010 and December 31, 2009 consist of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;September 30,&amp;#160;&lt;font style="DISPLAY: inline"&gt;2010&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM:
 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31, &lt;font style="DISPLAY: inline"&gt;2009&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td v
align="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Accounts payable&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;22,576&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="righ
t" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;18,638&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Accrued payroll and related costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"
 align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;23,583&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;
/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;9,444&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Accrued clinical trial expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&
gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;14,213&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;11,673&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style
="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Accrued property, plant, and equipment expenditures&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;8,495&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap
="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,883&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="
left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Accrued expenses, other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6,109&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&g
t;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6,207&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Payable to Bayer HealthCare&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FA
MILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 21.6pt; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&amp;#160;&amp;#160; -&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/
td&gt;&lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;1,186&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne
w roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;74,976&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="D
ISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;49,031&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
  <!--Capital expenditures-->
  <us-gaap:PaymentsToAcquireProductiveAssets unitRef="u000" decimals="-3" contextRef="c00035">67427000</us-gaap:PaymentsToAcquireProductiveAssets>
  <!--Capital expenditures-->
  <us-gaap:PaymentsToAcquireProductiveAssets unitRef="u000" decimals="-3" contextRef="c00001">75002000</us-gaap:PaymentsToAcquireProductiveAssets>
  <!--Total adjustments-->
  <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities unitRef="u000" decimals="-3" contextRef="c00035">227914000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
  <!--Total adjustments-->
  <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities unitRef="u000" decimals="-3" contextRef="c00001">5515000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
  <!--Increase (Decrease) in deferred revenue-->
  <us-gaap:IncreaseDecreaseInDeferredRevenue unitRef="u000" decimals="-3" contextRef="c00035">172660000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <!--Increase (Decrease) in deferred revenue-->
  <us-gaap:IncreaseDecreaseInDeferredRevenue unitRef="u000" decimals="-3" contextRef="c00001">-11379000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <!--Depreciation and amortization-->
  <us-gaap:DepreciationDepletionAndAmortization unitRef="u000" decimals="-3" contextRef="c00035">13601000</us-gaap:DepreciationDepletionAndAmortization>
  <!--Depreciation and amortization-->
  <us-gaap:DepreciationDepletionAndAmortization unitRef="u000" decimals="-3" contextRef="c00001">9312000</us-gaap:DepreciationDepletionAndAmortization>
  <!--Total liabilities and stockholders' equity-->
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="u000" decimals="-3" contextRef="c00028">942433000</us-gaap:LiabilitiesAndStockholdersEquity>
  <!--Total liabilities and stockholders' equity-->
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="u000" decimals="-3" contextRef="c00015">741202000</us-gaap:LiabilitiesAndStockholdersEquity>
  <!--Restricted cash-->
  <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent unitRef="u000" decimals="-3" contextRef="c00028">3400000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
  <!--Restricted cash-->
  <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent unitRef="u000" decimals="-3" contextRef="c00015">1600000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
  <!--ARCALYST (rilonacept) Product Revenue-->
  <regn:ArcalystRilonaceptProductRevenue contextRef="c00035">&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 36pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;2.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;ARCALYST&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; (rilonacept) Product Revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY
: Times New Roman"&gt;In February 2008, the Company received marketing approval from the U.S. Food and Drug Administration (&amp;#8220;FDA&amp;#8221;) for ARCALYST&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; Injection for Subcutaneous Use for the treatment of Cryopyrin-Associated Periodic Syndromes (&amp;#8220;CAPS&amp;#8221;).&amp;#160;&amp;#160;The Company had limited historical return experience for ARCALYST&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; beginning with initial sales in 2008 through the end of 2009; therefore, ARCALYST&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; net product sales were deferred until the right of return no longer existed and rebates could be reasonably estimated.&amp;#160;&amp;#160;Effective in the first quarter of 2010, the Company determined that it had accumulated sufficient historical data to reasonably e
stimate both product returns and rebates of ARCALYST&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;.&amp;#160;&amp;#160;As a result, $4.8 million of previously deferred ARCALYST&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; net product sales were recognized as revenue in the first quarter of 2010.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;ARCALYST&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; net product sales totaled $4.9 million and $5.0 million for the three months ended September 30, 2010 and 2009, respectively, and $20.0 million and $13.4 million for the nine months ended September 30, 2010 and 2009,
 respectively.&amp;#160;&amp;#160;ARCALYST&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174; &lt;/font&gt;net product sales during the first nine months of 2010 included $15.2 million of net product sales made during this period and $4.8 million of previously deferred net product sales, as described above.&amp;#160;&amp;#160;There was no deferred ARCALYST&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; net product sales revenue at September 30, 2010.&amp;#160;&amp;#160;At September 30, 2009, deferred ARCALYST&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; net product sales revenue was $5.0 million.&amp;#160;&amp;#160;The effect of this change in estimate related to ARCALYST&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; net product sales revenue was to lower the Company&amp;#8217;s net loss per share by $0.06 for
 the nine months ended September 30, 2010.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Cost of goods sold related to ARCALYST&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; sales, which consisted primarily of royalties, totaled $0.4 million and $0.5 million for the three months ended September 30, 2010 and 2009, respectively, and $1.5 million and $1.3 million for the nine months ended September 30, 2010 and 2009, respectively.&amp;#160;&amp;#160;To date, ARCALYST&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; shipments to the Company&amp;#8217;s customers have consisted of supplies of inventory manufactured and expensed prior to FDA approval of ARCALYST&lt;font 
style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; for the treatment of CAPS; therefore, the costs of these supplies were not included in costs of goods sold.&amp;#160;&amp;#160;At both September 30, 2010 and December 31, 2009, the Company had $0.4 million of inventoried work-in-process costs related to ARCALYST&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;, which is included in prepaid expenses and other current assets.&lt;/font&gt;&lt;/div&gt;</regn:ArcalystRilonaceptProductRevenue>
  <!--Entity Filer Category-->
  <dei:EntityFilerCategory contextRef="c00035">Large Accelerated Filer</dei:EntityFilerCategory>
  <!--Entity Common Stock, Shares Outstanding-->
  <dei:EntityCommonStockSharesOutstanding unitRef="u001" decimals="0" contextRef="c00044">80111128</dei:EntityCommonStockSharesOutstanding>
  <!--Other collaboration revenue-->
  <regn:OtherCollaborationRevenue unitRef="u000" decimals="-3" contextRef="c00042">13761000</regn:OtherCollaborationRevenue>
  <!--Other collaboration revenue-->
  <regn:OtherCollaborationRevenue unitRef="u000" decimals="-3" contextRef="c00043">32153000</regn:OtherCollaborationRevenue>
  <!--Other collaboration revenue-->
  <regn:OtherCollaborationRevenue unitRef="u000" decimals="-3" contextRef="c00035">40483000</regn:OtherCollaborationRevenue>
  <!--Other collaboration revenue-->
  <regn:OtherCollaborationRevenue unitRef="u000" decimals="-3" contextRef="c00001">54947000</regn:OtherCollaborationRevenue>
  <!--Accumulated other comprehensive income-->
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax unitRef="u000" decimals="-3" contextRef="c00028">-175000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <!--Accumulated other comprehensive income-->
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax unitRef="u000" decimals="-3" contextRef="c00015">1044000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <!--Total current liabilities-->
  <us-gaap:LiabilitiesCurrent unitRef="u000" decimals="-3" contextRef="c00028">133833000</us-gaap:LiabilitiesCurrent>
  <!--Total current liabilities-->
  <us-gaap:LiabilitiesCurrent unitRef="u000" decimals="-3" contextRef="c00015">93575000</us-gaap:LiabilitiesCurrent>

</xbrl>
</XBRL>
